1,852 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Bought by Forum Financial Management LP

Forum Financial Management LP acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,852 shares of the medical device company’s stock, valued at approximately $204,000.

Several other hedge funds also recently added to or reduced their stakes in the stock. Innealta Capital LLC acquired a new stake in shares of Cooper Companies in the 2nd quarter valued at about $25,000. Covestor Ltd raised its stake in Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after buying an additional 208 shares in the last quarter. Crewe Advisors LLC lifted its holdings in Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after buying an additional 252 shares during the last quarter. Tortoise Investment Management LLC grew its position in shares of Cooper Companies by 75.4% in the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after acquiring an additional 169 shares in the last quarter. Finally, Clearstead Trust LLC bought a new stake in shares of Cooper Companies in the 1st quarter valued at approximately $36,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on COO. Wells Fargo & Company raised their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Morgan Stanley increased their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and raised their target price for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Finally, Piper Sandler upped their target price on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Insider Activity at Cooper Companies

In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock worth $27,637,427 over the last quarter. 2.00% of the stock is currently owned by company insiders.

Cooper Companies Trading Up 0.3 %

Shares of COO stock opened at $105.21 on Wednesday. The Cooper Companies, Inc. has a 1 year low of $80.48 and a 1 year high of $112.38. The firm has a market capitalization of $20.95 billion, a PE ratio of 58.61, a price-to-earnings-growth ratio of 2.28 and a beta of 0.99. The stock has a fifty day moving average of $106.99 and a two-hundred day moving average of $97.26. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.84 earnings per share. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.